[1]
Mowry JB, Spyker DA, Brooks DE, Zimmerman A, Schauben JL. 2015 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 33rd Annual Report. Clinical toxicology (Philadelphia, Pa.). 2016 Dec:54(10):924-1109. doi: 10.1080/15563650.2016.1245421. Epub
[PubMed PMID: 28004588]
[2]
Litovitz TL, Klein-Schwartz W, Dyer KS, Shannon M, Lee S, Powers M. 1997 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 1998 Sep:16(5):443-97
[PubMed PMID: 9725964]
[3]
Litovitz TL, Klein-Schwartz W, White S, Cobaugh DJ, Youniss J, Omslaer JC, Drab A, Benson BE. 2000 Annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 2001 Sep:19(5):337-95
[PubMed PMID: 11555795]
[4]
Watson WA, Litovitz TL, Klein-Schwartz W, Rodgers GC Jr, Youniss J, Reid N, Rouse WG, Rembert RS, Borys D. 2003 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System. The American journal of emergency medicine. 2004 Sep:22(5):335-404
[PubMed PMID: 15490384]
[5]
Smulyan H. The Beat Goes On: The Story of Five Ageless Cardiac Drugs. The American journal of the medical sciences. 2018 Nov:356(5):441-450. doi: 10.1016/j.amjms.2018.04.011. Epub 2018 Apr 25
[PubMed PMID: 30055757]
[6]
Feinberg M. The problems of anticholinergic adverse effects in older patients. Drugs & aging. 1993 Jul-Aug:3(4):335-48
[PubMed PMID: 8369593]
[7]
Tune LE. Anticholinergic effects of medication in elderly patients. The Journal of clinical psychiatry. 2001:62 Suppl 21():11-4
[PubMed PMID: 11584981]
[8]
Vanderhoff BT, Mosser KH. Jimson weed toxicity: management of anticholinergic plant ingestion. American family physician. 1992 Aug:46(2):526-30
[PubMed PMID: 1636566]
[9]
Tiongson J, Salen P. Mass ingestion of Jimson Weed by eleven teenagers. Delaware medical journal. 1998 Nov:70(11):471-6
[PubMed PMID: 9846457]
[10]
Weiner AL, Bayer MJ, McKay CA Jr, DeMeo M, Starr E. Anticholinergic poisoning with adulterated intranasal cocaine. The American journal of emergency medicine. 1998 Sep:16(5):517-20
[PubMed PMID: 9725971]
[11]
Ridder WP, Klimek M, Rupreht J. [Physostigmine for the immediate treatment of a patient with the central anticholinergic syndrome induced by cocaine cut with atropine]. Nederlands tijdschrift voor geneeskunde. 2005 Jul 23:149(30):1701-3
[PubMed PMID: 16104118]
[12]
Hamilton RJ, Perrone J, Hoffman R, Henretig FM, Karkevandian EH, Marcus S, Shih RD, Blok B, Nordenholz K. A descriptive study of an epidemic of poisoning caused by heroin adulterated with scopolamine. Journal of toxicology. Clinical toxicology. 2000:38(6):597-608
[PubMed PMID: 11185966]
[13]
Reilly JF Jr, Weisse ME. Topically induced diphenhydramine toxicity. The Journal of emergency medicine. 1990 Jan-Feb:8(1):59-61
[PubMed PMID: 2351800]
[15]
Gummin DD, Mowry JB, Spyker DA, Brooks DE, Fraser MO, Banner W. 2016 Annual Report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 34th Annual Report. Clinical toxicology (Philadelphia, Pa.). 2017 Dec:55(10):1072-1252. doi: 10.1080/15563650.2017.1388087. Epub 2017 Nov 29
[PubMed PMID: 29185815]
[16]
Mitchelson F. Muscarinic receptor agonists and antagonists: effects on ocular function. Handbook of experimental pharmacology. 2012:(208):263-98. doi: 10.1007/978-3-642-23274-9_12. Epub
[PubMed PMID: 22222703]
[17]
Harvey RD. Muscarinic receptor agonists and antagonists: effects on cardiovascular function. Handbook of experimental pharmacology. 2012:(208):299-316. doi: 10.1007/978-3-642-23274-9_13. Epub
[PubMed PMID: 22222704]
[18]
Ehlert FJ, Pak KJ, Griffin MT. Muscarinic agonists and antagonists: effects on gastrointestinal function. Handbook of experimental pharmacology. 2012:(208):343-74. doi: 10.1007/978-3-642-23274-9_15. Epub
[PubMed PMID: 22222706]
[19]
Scavone JM, Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI. Pharmacokinetics and pharmacodynamics of diphenhydramine 25 mg in young and elderly volunteers. Journal of clinical pharmacology. 1998 Jul:38(7):603-9
[PubMed PMID: 9702844]
[20]
Renner UD, Oertel R, Kirch W. Pharmacokinetics and pharmacodynamics in clinical use of scopolamine. Therapeutic drug monitoring. 2005 Oct:27(5):655-65
[PubMed PMID: 16175141]
[21]
Ali-Melkkilä T, Kanto J, Iisalo E. Pharmacokinetics and related pharmacodynamics of anticholinergic drugs. Acta anaesthesiologica Scandinavica. 1993 Oct:37(7):633-42
[PubMed PMID: 8249551]
[22]
Holstege CP, Borek HA. Toxidromes. Critical care clinics. 2012 Oct:28(4):479-98. doi: 10.1016/j.ccc.2012.07.008. Epub 2012 Aug 27
[PubMed PMID: 22998986]
[23]
Lin TJ, Nelson LS, Tsai JL, Hung DZ, Hu SC, Chan HM, Deng JF. Common toxidromes of plant poisonings in Taiwan. Clinical toxicology (Philadelphia, Pa.). 2009 Feb:47(2):161-8. doi: 10.1080/15563650802077924. Epub
[PubMed PMID: 18788001]
[24]
Thakur AC, Aslam AK, Aslam AF, Vasavada BC, Sacchi TJ, Khan IA. QT interval prolongation in diphenhydramine toxicity. International journal of cardiology. 2005 Feb 15:98(2):341-3
[PubMed PMID: 15686790]
[25]
Sharma AN, Hexdall AH, Chang EK, Nelson LS, Hoffman RS. Diphenhydramine-induced wide complex dysrhythmia responds to treatment with sodium bicarbonate. The American journal of emergency medicine. 2003 May:21(3):212-5
[PubMed PMID: 12811715]
[26]
Derinoz O, Emeksiz HC. Use of physostigmine for cyclopentolate overdose in an infant. Pediatrics. 2012 Sep:130(3):e703-5. doi: 10.1542/peds.2011-3038. Epub 2012 Aug 20
[PubMed PMID: 22908101]
[27]
Bross MH, Nash BT Jr, Carlton FB Jr. Heat emergencies. American family physician. 1994 Aug:50(2):389-96, 398
[PubMed PMID: 8042574]
[28]
Green R, Sitar DS, Tenenbein M. Effect of anticholinergic drugs on the efficacy of activated charcoal. Journal of toxicology. Clinical toxicology. 2004:42(3):267-72
[PubMed PMID: 15362593]
[29]
Isbister GK, Kumar VV. Indications for single-dose activated charcoal administration in acute overdose. Current opinion in critical care. 2011 Aug:17(4):351-7. doi: 10.1097/MCC.0b013e328348bf59. Epub
[PubMed PMID: 21716104]
Level 3 (low-level) evidence
[30]
Holger JS, Harris CR, Engebretsen KM. Physostigmine, sodium bicarbonate, or hypertonic saline to treat diphenhydramine toxicity. Veterinary and human toxicology. 2002 Feb:44(1):1-4
[PubMed PMID: 11824763]
[31]
Arens AM, Shah K, Al-Abri S, Olson KR, Kearney T. Safety and effectiveness of physostigmine: a 10-year retrospective review{sup/}. Clinical toxicology (Philadelphia, Pa.). 2018 Feb:56(2):101-107. doi: 10.1080/15563650.2017.1342828. Epub 2017 Jul 13
[PubMed PMID: 28703024]
Level 2 (mid-level) evidence
[32]
Rosenbaum C, Bird SB. Timing and frequency of physostigmine redosing for antimuscarinic toxicity. Journal of medical toxicology : official journal of the American College of Medical Toxicology. 2010 Dec:6(4):386-92. doi: 10.1007/s13181-010-0077-7. Epub
[PubMed PMID: 20405266]
[33]
Pentel P, Peterson CD. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Annals of emergency medicine. 1980 Nov:9(11):588-90
[PubMed PMID: 7001962]
[34]
Abdelmalek D, Schwarz ES, Sampson C, Halcomb SE, McCammon C, Arroyo-Plasencia A, Stenger A, Krehbiel N, Mullins ME. Life-threatening diphenhydramine toxicity presenting with seizures and a wide complex tachycardia improved with intravenous fat emulsion. American journal of therapeutics. 2014 Nov-Dec:21(6):542-4. doi: 10.1097/MJT.0b013e318281191b. Epub
[PubMed PMID: 24096706]
[35]
Perrone J, Chu J, Stecker MM. Viral encephalitis masquerading as a fulminant anticholinergic toxidrome. Journal of toxicology. Clinical toxicology. 1997:35(6):627-33
[PubMed PMID: 9365431]
[36]
Thomas A, Nallur DG, Jones N, Deslandes PN. Diphenhydramine abuse and detoxification: a brief review and case report. Journal of psychopharmacology (Oxford, England). 2009 Jan:23(1):101-5. doi: 10.1177/0269881107083809. Epub 2008 Feb 28
[PubMed PMID: 18308811]
Level 3 (low-level) evidence
[37]
Grande G, Tramacere I, Vetrano DL, Clerici F, Pomati S, Mariani C, Filippini G, REMIND Study Group (Rete Milanese Integrata per le Demenze). Role of anticholinergic burden in primary care patients with first cognitive complaints. European journal of neurology. 2017 Jul:24(7):950-955. doi: 10.1111/ene.13313. Epub 2017 May 15
[PubMed PMID: 28503836]
[38]
Balling L, Erstad BL, Weibel K. Impact of a transition-of-care pharmacist during hospital discharge. Journal of the American Pharmacists Association : JAPhA. 2015 Jul-Aug:55(4):443-8. doi: 10.1331/JAPhA.2015.14087. Epub
[PubMed PMID: 26161488]